|
NZ520976A
(en)
|
1999-11-19 |
2005-01-28 |
Csl Ltd |
Vaccine compositions
|
|
HU230847B1
(en)
|
2000-05-19 |
2018-08-28 |
Corixa Corp |
Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds
|
|
EP1382352A1
(de)
|
2002-07-19 |
2004-01-21 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
Bisacyloxypropylcystein-Konjugate und deren Verwendung
|
|
AU2003250586B2
(en)
|
2002-08-12 |
2010-09-23 |
The Council Of The Queensland Institute Of Medical Research |
Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
|
|
BR0313101A
(pt)
|
2002-08-12 |
2005-06-28 |
Queensland Inst Med Res |
Novos lipopeptìdeos imunogênicos que compreendem epitopos de linfócitos t-helper e linfócitos t citotóxicos (ctl), e métodos para sua produção e uso
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
US20060002941A1
(en)
|
2004-01-23 |
2006-01-05 |
Vievax Corp. |
Compositions comprising immune response altering agents and methods of use
|
|
WO2005079419A2
(en)
|
2004-02-17 |
2005-09-01 |
The Regents Of The University Of California |
Methods of treating immunopathological disorders
|
|
GB0405634D0
(en)
|
2004-03-12 |
2004-04-21 |
Univ Southampton |
Anti-virus therapy for respiratory diseases
|
|
GB0411411D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
EP2460533A3
(en)
|
2004-10-18 |
2014-01-08 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
|
EP1666056A1
(en)
|
2004-12-06 |
2006-06-07 |
Bestewil Holding B.V. |
Cancer vaccine vesicles
|
|
US8420102B2
(en)
|
2006-03-07 |
2013-04-16 |
Vaxinnate Corporation |
Compositions that include hemagglutinin
|
|
NZ556004A
(en)
|
2004-12-21 |
2010-05-28 |
Vaxinnate Corp |
Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein
|
|
CN101151280A
(zh)
|
2005-02-08 |
2008-03-26 |
昆士兰医学研究学院委员会 |
免疫原性分子
|
|
US7560436B2
(en)
|
2005-02-22 |
2009-07-14 |
The Regents Of The University Of California |
Methods of treating gastrointestinal inflammation
|
|
EP1787660A1
(en)
*
|
2005-11-22 |
2007-05-23 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
|
|
WO2008085549A2
(en)
|
2006-07-28 |
2008-07-17 |
Board Of Regents Of The University Of Texas System |
Compositions and methods for stimulation of lung innate immunity
|
|
AU2014202674B2
(en)
*
|
2007-05-04 |
2014-08-14 |
Marina Biotech, Inc. |
Amino acid lipids and uses thereof
|
|
AU2008310313C1
(en)
|
2007-10-09 |
2015-02-12 |
Ena Respiratory Pty Ltd |
A method of transfection and compositions therefor
|
|
WO2009137103A2
(en)
|
2008-05-09 |
2009-11-12 |
Ourth Donald D |
Anti-cancer/anti-viral compounds and methods of use
|
|
US8728465B2
(en)
|
2008-06-17 |
2014-05-20 |
Cedars-Sinai Medical Center |
Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
|
|
WO2010028246A2
(en)
|
2008-09-05 |
2010-03-11 |
Id Biomedical Corporation Of Quebec |
Novel compositions and adjuvants
|
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
CN103800906B
(zh)
|
2009-03-25 |
2017-09-22 |
德克萨斯大学系统董事会 |
用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物
|
|
JP2012523379A
(ja)
|
2009-04-09 |
2012-10-04 |
ザ ユニバーシティー オブ メルボルン |
免疫原性組成物およびその使用
|
|
GB0907989D0
(en)
|
2009-05-08 |
2009-06-24 |
Hybrid Systems Ltd |
Multivalent adjuvant display
|
|
EP2338521A1
(en)
|
2009-12-28 |
2011-06-29 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Lipopeptide- and lipoprotein-conjugates and its use
|
|
EA031379B1
(ru)
*
|
2010-03-23 |
2018-12-28 |
Новартис Аг |
Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
|
|
EP2618842B1
(en)
|
2010-09-22 |
2019-04-24 |
Ena Therapeutics Pty Ltd |
Novel immunostimulatory method
|
|
CN113876945A
(zh)
*
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
EP3604271A1
(en)
|
2013-06-28 |
2020-02-05 |
Auckland Uniservices Limited |
Peptides for amino acid and peptide conjugates and conjugation process
|
|
US20170274068A1
(en)
|
2014-09-12 |
2017-09-28 |
The University Of Melbourne |
Immunological reagent
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
JP2016216593A
(ja)
|
2015-05-19 |
2016-12-22 |
株式会社リコー |
反応材、熱交換器及びケミカルヒートポンプ
|
|
EP3328418A1
(en)
|
2015-07-29 |
2018-06-06 |
Novartis AG |
Combination therapies comprising antibody molecules to pd-1
|
|
TW201735952A
(zh)
*
|
2016-02-26 |
2017-10-16 |
瑪格蕾特 安 布萊博 |
胺基酸及肽共軛物以及共軛過程
|
|
CN110461351B
(zh)
*
|
2017-03-31 |
2024-03-26 |
艾娜呼吸私人有限公司 |
用tlr2激动剂治疗呼吸道感染
|
|
NL2018803B1
(en)
*
|
2017-04-27 |
2018-11-05 |
Academisch Ziekenhuis Leiden Handelend Onder De Naam Leids Univ Medisch Centrum/ H O D N Lumc |
Adjuvant compounds
|
|
EP3676250A4
(en)
*
|
2017-08-30 |
2021-05-26 |
Auckland Uniservices Limited |
PEPTIDE CONJUGATES, CONJUGATION METHODS AND USES THEREOF
|
|
AU2018391325B2
(en)
|
2017-12-21 |
2024-07-11 |
Axelia Oncology Pty Ltd |
Optimised compounds
|
|
WO2019119069A1
(en)
|
2017-12-21 |
2019-06-27 |
Ena Therapeutics Pty Ltd |
Administration of a tlr2 agonist for the treatment or prevention of a respiratory condition associated with an infectious agent
|
|
MX2021015961A
(es)
*
|
2019-06-26 |
2022-03-22 |
Ena Respiratory Pty Ltd |
Moleculas novedosas.
|
|
US20220347146A1
(en)
|
2019-09-04 |
2022-11-03 |
Axelia Oncology Pty Ltd |
Cancer treatment
|
|
AU2020340468A1
(en)
|
2019-09-04 |
2022-03-24 |
Axelia Oncology Pty Ltd |
Cancer immunotherapy
|
|
WO2021237291A1
(en)
|
2020-05-26 |
2021-12-02 |
Axelia Oncology Pty Ltd |
Treatment of coronavirus
|